follow @ClinPsychNews
RSS Feeds
Find Us on Facebook

Bipolar Disorder: More Recurrences in Teens with Comorbid Anxiety

By: HEIDI SPLETE, Clinical Psychiatry News Digital Network

TORONTO – Children and teens with bipolar disorder had a significantly longer recovery time and more recurrences if they had comorbid anxiety disorders, based on data from a longitudinal study.

Comorbid anxiety disorder has been previously associated with worse prognosis in teens with bipolar disorders, but the finding has based primarily on cross-sectional studies, and longitudinal data are limited, said Dr. Regina Sala of Columbia University in New York and her colleagues.

Data from the Course and Outcomes of Bipolar Youth study were reviewed for 413 youth aged 7-17 years (average age 13 years) with bipolar disorder; 256 study participants had comorbid anxiety.

The patients were assessed weekly for 5 years. After researchers adjusted for confounding variables, 37% of the children and teens with comorbid anxiety disorders and 55% of those without anxiety were asymptomatic on a weekly basis.

In addition, bipolar youth with comorbid anxiety took significantly longer to recover from their index episodes; the median times to recovery were 138 weeks for those with anxiety and 87 weeks for those without anxiety. Recurrence rates also were significantly higher at 76% for bipolar youth with comorbid anxiety and 57% for those without comorbid anxiety. The median time to recurrence was significantly shorter at 37 weeks in the comorbid group and 48 weeks with bipolar disorder alone.

The results suggest that characteristics of youth with comorbid bipolar and anxiety disorders include more syndromal and subsyndromal mixed cycling, more depression, and less euthymia than did bipolar youth without comorbid anxiety, the researchers said.

Dr. Sala was supported by a grant from the Alicia Koplowitz Foundation. Several study coauthors have received financial support and/or served as consultants or on advisory boards for multiple companies including Pfizer, Abbott, Schering-Plough, Bristol-Myers Squibb, and Forest.

10/31/11  

FROM THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY

Bookmark and Share


Submitting your vote...
Not rated yet. Be the first who rates this item!
Click the rating bar to rate this item.

Vitals

Major Finding: After adjustment for confounding variables, 37% of youths with bipolar disorder and comorbid anxiety disorders and 55% of those with bipolar disorder without anxiety were asymptomatic on a weekly basis.

Data Source: 413 youth, aged 7 to 17 years, who were part of the longitudinal Course and Outcomes of Bipolar Youth study.

Disclosures: Dr. Sala was supported by a grant from the Alicia Koplowitz Foundation. Several study coauthors have received financial support and/or served as consultants or on advisory boards for multiple companies including Pfizer, Abbott, Schering-Plough, Bristol-Myers Squibb, and Forest.

I would like to receive Clinical Psychiatry News E-Newsletter The Cognoscenti each week.


Specialty Focus
Sponsored by


calendar
May 24 - 27
Chicago, IL
Association for Psychological Science (APS): Annual Convention
May 29 - Jun 1
Phoenix, AZ
National Institute of Mental Health (NIMH): New Clinical Drug Evaluation Unit (NCDEU)
Jun 3 - 7
Stockholm,
Collegium Internationale Neuro-Psychopharmacologicum (CINP): World Congress
Jun 5 - 10
Kona, HI
International Behavioral Neuroscience Society (IBNS): Annual Meeting
Jun 12 - 17
Chicago, IL
American Psychoanalytic Association (APsaA): 101st Annual Meeting
Jun 18 - 26
Rapid City, SD
Reclaiming Youth International: 19th Annual Black Hills Seminars
Jun 23 - 27
San Francisco, CA
Research Society on Alcoholism (RSA): Annual Scientific Conference
Jul 10 - 13
Liverpool,
Royal College of Psychiatrists: Annual Meeting
Jul 21 - 28
Dpart Venice,
Primary Care: Mental Health Issues with a Focus on Drugs and Behavior
Jul 21 - 25
Paris,
International Association for Child & Adolescent Psych & Allied Professions (IACAPAP): World Congress
More Calendar »